Riluzole

Riluzole may protect motor nerves from further deterioration by reducing glutamate levels in the brain and spinal cord by blocking its release from nerve terminals.

Status

Type: Small Molecule
Stage: FDA-Approved
Status: FDA-Approved

TDI Says:

Although it only has modest effects on disease progression, riluzole is the only FDA-approved drug for ALS.

Learn More

  • Postcard from Australia

    Neuroscience Research Australia’s Steve Vucic PhD discusses emerging combination treatment strategies including riluzole that may reduce hyperexcitability, a potential early step in the disease.

Published Results

Comment on this Topic

(All comments are moderated before they appear here.)